Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$15.03 - $16.32 $32,585 - $35,381
2,168 Added 18.11%
14,141 $218,000
Q2 2023

Aug 09, 2023

BUY
$15.57 - $17.11 $5,278 - $5,800
339 Added 2.91%
11,973 $188,000
Q1 2023

May 11, 2023

BUY
$15.28 - $16.48 $177,767 - $191,728
11,634 New
11,634 $191,000
Q3 2022

Nov 10, 2022

SELL
$12.8 - $28.65 $77,235 - $172,874
-6,034 Reduced 20.87%
22,884 $297,000
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $212,124 - $243,005
-16,168 Reduced 35.86%
28,918 $406,000
Q1 2022

Apr 27, 2022

BUY
$13.54 - $15.35 $196,113 - $222,329
14,484 Added 47.33%
45,086 $646,000
Q4 2021

Feb 11, 2022

BUY
$13.17 - $16.4 $101,066 - $125,853
7,674 Added 33.47%
30,602 $417,000
Q3 2021

Nov 12, 2021

BUY
$16.3 - $17.26 $94,474 - $100,038
5,796 Added 33.83%
22,928 $376,000
Q2 2021

Aug 10, 2021

SELL
$16.55 - $18.64 $125,184 - $140,992
-7,564 Reduced 30.63%
17,132 $288,000
Q1 2021

Apr 30, 2021

BUY
$16.71 - $19.9 $412,670 - $491,450
24,696 New
24,696 $451,000
Q4 2020

Feb 08, 2021

SELL
$15.39 - $18.97 $300,135 - $369,952
-19,502 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$17.1 - $19.19 $91,040 - $102,167
5,324 Added 37.55%
19,502 $348,000
Q2 2020

Aug 12, 2020

BUY
$14.59 - $19.5 $206,857 - $276,471
14,178 New
14,178 $254,000
Q1 2020

Apr 29, 2020

SELL
$13.02 - $20.31 $252,405 - $393,729
-19,386 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$16.88 - $20.83 $55,737 - $68,780
-3,302 Reduced 14.55%
19,386 $382,000
Q3 2019

Nov 08, 2019

BUY
$16.15 - $17.99 $366,411 - $408,157
22,688 New
22,688 $390,000
Q2 2019

Jul 24, 2019

SELL
$16.58 - $20.49 $269,491 - $333,044
-16,254 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$16.7 - $21.52 $271,441 - $349,786
16,254 New
16,254 $331,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.